New research published in JAMA Network Open from USC Norris Comprehensive Cancer Center, part of Keck Medicine of USC, suggests that among all cancer survivors, male adolescents and young adults (AYA) have the highest rate ...
Nov 18, 2024
0
34
The social media platform TikTok has become a cultural phenomenon, influencing the behavior and taste of its users in almost every area of life. From dance trends to skincare and make-up products, health hacks to fad diets, ...
Nov 13, 2024
0
0
Scientists at deCODE genetics/Amgen, and their collaborators have discovered six novel genes with rare germline variants that associate with cancer risk. The findings are published today in Nature Genetics under the title ...
Oct 29, 2024
0
17
A radiopharmaceutical therapy that has successfully extended progression-free survival for patients with neuroendocrine tumors shows early promise for delivering similar benefits to patients with difficult-to-treat meningioma, ...
Sep 29, 2024
0
0
Patients with primary thyroid cancer who receive radioactive iodine therapy have an elevated risk for melanoma and other nonkeratinocyte skin cancers when limiting the cancer site to the head and neck, according to a study ...
Sep 27, 2024
0
0
Cancer incidence trends in 2021 largely returned to what they were before the COVID-19 pandemic, according to a study by researchers at the National Institutes of Health (NIH). However, there was little evidence of a rebound ...
Sep 24, 2024
0
0
Patients with low-risk cancers undergoing active surveillance face a favorable long-term prognosis. David Haggstrom, M.D., MAS, makes the case that it's time for the medical field to help manage the anxiety caused by waiting.
Sep 16, 2024
0
0
A new research perspective titled "Targeting the multifaceted BRAF in cancer: New directions" has been published in Oncotarget.
Aug 12, 2024
0
0
Obesity increases the risk of developing a number of cancers, so it stands to reason that drugs that reduce body weight should also reduce the risk of developing these cancers.
Jul 13, 2024
0
1
A class of diabetes medications, which include the best-selling drug Ozempic, are associated with a reduced risk of certain obesity-related cancers, according to a study released Friday.
Jul 6, 2024
0
139
